Foundation Convenes Partnership to Study Childhood Malnutrition Worldwide
Bethesda, MD - Together with the Fogarty International Center (FIC), part of the National Institutes of Health, and funded by the Bill & Melinda Gates Foundation, researchers will study the linkages of malnutrition and intestinal infections and how they affect children in the developing world.
The Biomarkers Consortium Completes First Project to Show that Adiponectin is a Predictive Biomarker for Type 2 Diabetes
Bethesda, MD – The use of adiponectin, a hormone derived from fat cells, which is abundant in plasma and easy to measure through commercially available kits, was confirmed as a robust biomarker predictive of glycemic efficacy in Type 2 diabetes and healthy subjects, after treatment with peroxisome proliferator-activated receptor-agonists (PPAR), but not after treatment with non-PPAR drugs such as metformin.
2009 Inaugural mHealth Summit Brings Together Health, Technology and Policy Communities to Advance Technological Innovation in Global Healthcare
WASHINGTON, DC -- October 29, 2009 -- The 2009 mHealth (Mobile Health) Summit, organized by the Foundation for the National Institutes of Health (FNIH), today opens an unprecedented two-day summit bringing together more than 800 public and private sector science, medical, policy and mobile technology experts to develop a new roadmap related to the integration of science and wireless solutions to improve public health delivery, particularly to underserved populations, in the U.S. and around the world.
Boo! Run for Life 10K Teams Up with Giuliana and Bill Rancic
BETHESDA, MD – September 11, 2009 – The Boo! Run for Life 10K today announced that it has teamed up with anchor and managing editor of E! News Giuliana Rancic, and television host, speaker, and entrepreneur Bill Rancic in support of renal cell (or kidney) cancer research.
Unprecedented Product Donation by sanofi-aventis in the U.S.
Bethesda, MD and Bridgewater, NJ – August 5, 2009 – Today, the Foundation for the National Institutes of Health and sanofi-aventis announced an unprecedented donation by the global pharmaceutical leader providing approximately $1.3 million in pharmaceutical therapies for ongoing use in clinical trials and other therapeutic treatments at the National Institutes of Health (NIH) C
Share This Page |
Press Inquiries |
Alison Hendrie
ahendrie [at] rubenstein [dot] com
(212) 843-8029
Alexandra Sturm
asturm [at] rubenstein [dot] com
(212) 843-9342
FNIH on Twitter |
FNIH in the News |
Latest Blog Posts |
